Weiping Zheng

952 total citations
62 papers, 699 citations indexed

About

Weiping Zheng is a scholar working on Surgery, Molecular Biology and Hepatology. According to data from OpenAlex, Weiping Zheng has authored 62 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Surgery, 19 papers in Molecular Biology and 19 papers in Hepatology. Recurrent topics in Weiping Zheng's work include Organ Transplantation Techniques and Outcomes (28 papers), Liver Disease and Transplantation (14 papers) and MicroRNA in disease regulation (10 papers). Weiping Zheng is often cited by papers focused on Organ Transplantation Techniques and Outcomes (28 papers), Liver Disease and Transplantation (14 papers) and MicroRNA in disease regulation (10 papers). Weiping Zheng collaborates with scholars based in China, Hungary and United States. Weiping Zheng's co-authors include Hongli Song, Longlong Wu, Xiaorong Tian, Xuan Tian, Shen Zhong-yang, Yang Liu, Xiang Li, Chengbin Yu, Dong Sun and Jia‐Yong Zhang and has published in prestigious journals such as PLoS ONE, Journal of Pharmacology and Experimental Therapeutics and The Journal of Organic Chemistry.

In The Last Decade

Weiping Zheng

62 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiping Zheng China 14 244 202 200 146 119 62 699
Xiuling Li China 16 380 1.6× 77 0.4× 198 1.0× 42 0.3× 64 0.5× 46 788
Wei-Ping He China 10 82 0.3× 186 0.9× 37 0.2× 38 0.3× 241 2.0× 31 476
Lujun Song China 12 191 0.8× 263 1.3× 35 0.2× 20 0.1× 104 0.9× 19 575
Hongchuan Zhao China 14 171 0.7× 192 1.0× 81 0.4× 82 0.6× 146 1.2× 39 645
Phillip J. Johnson United States 8 177 0.7× 90 0.4× 79 0.4× 54 0.4× 140 1.2× 12 526
Cristina Napoli Italy 11 246 1.0× 200 1.0× 118 0.6× 24 0.2× 69 0.6× 20 564
Jane Birtwistle United Kingdom 12 209 0.9× 73 0.4× 66 0.3× 21 0.1× 117 1.0× 21 554
Luis T. Campos United States 13 201 0.8× 74 0.4× 140 0.7× 22 0.2× 57 0.5× 29 726
Yixing Chen China 16 257 1.1× 223 1.1× 111 0.6× 10 0.1× 97 0.8× 49 782
Zhilong Ma China 16 165 0.7× 205 1.0× 59 0.3× 32 0.2× 9 0.1× 34 476

Countries citing papers authored by Weiping Zheng

Since Specialization
Citations

This map shows the geographic impact of Weiping Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiping Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiping Zheng more than expected).

Fields of papers citing papers by Weiping Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiping Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiping Zheng. The network helps show where Weiping Zheng may publish in the future.

Co-authorship network of co-authors of Weiping Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Weiping Zheng. A scholar is included among the top collaborators of Weiping Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiping Zheng. Weiping Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yüxin, et al.. (2024). Ferrostatin-1 improves prognosis and regulates gut microbiota of steatotic liver transplantation recipients in rats. Future Microbiology. 19(5). 413–429. 1 indexed citations
2.
Zhai, Lili, Weiping Zheng, Chong Dong, et al.. (2023). The value of 18F‐FDG PET/CT quantitative indexes in the diagnosis of nondestructive posttransplant lymphoproliferative disorders after pediatric liver transplantation. Pediatric Transplantation. 27(5). e14501–e14501. 1 indexed citations
3.
Zhang, Zhixin, et al.. (2023). Impact of different ischemia times on biliary stricture after living donor liver transplantation with biliary atresia. Liver Transplantation. 29(6). 607–617. 1 indexed citations
4.
Xu, Min, Chong Dong, Kai Wang, et al.. (2023). Impact of donor age on short-term outcomes after pediatric split liver transplantation. Frontiers in Pediatrics. 11. 1131629–1131629. 3 indexed citations
5.
Li, Hongchen, et al.. (2022). Mechanistic Insights into Tf2O-Promoted Electrophilic Activation of 2-Propynamides and a New Synthesis of 2,4-Disubstituted Quinolines. Organic Letters. 24(48). 8806–8811. 4 indexed citations
6.
Dong, Chong, Kai Wang, Wei Zhang, et al.. (2022). Impact of allograft types on outcomes after pediatric liver transplantation due to biliary atresia. Pediatric Transplantation. 26(7). e14342–e14342. 1 indexed citations
7.
Li, Hongchen, Weiping Zheng, Xingyong Wang, et al.. (2022). Tandem Synthesis of 2-Azaspiro[4.5]deca-1,6,9-trien-8-ones Based on Tf2O-Promoted Activation of N-(2-Propyn-1-yl) Amides. The Journal of Organic Chemistry. 88(1). 525–533. 1 indexed citations
8.
Dong, Chong, Kai Wang, Wei Zhang, et al.. (2022). The impact of portal vein reconstruction on portal vein complications after pediatric living-donor liver transplantation with left lobe graft. Surgery. 173(2). 537–543. 2 indexed citations
9.
Dong, Chong, Kai Wang, Wei Zhang, et al.. (2022). Nomograms for Predicting the Incidence of Late-Onset Acute Cellular Rejection in Patients After Pediatric Liver Transplantation. Frontiers in Pediatrics. 10. 915795–915795. 2 indexed citations
13.
Liu, Yang, et al.. (2017). Effects of heme oxygenase-1-modified bone marrow mesenchymal stem cells on microcirculation and energy metabolism following liver transplantation. World Journal of Gastroenterology. 23(19). 3449–3449. 12 indexed citations
14.
Pan, Hongying, Wenyu Song, Weiping Zheng, et al.. (2017). Long‐term outcome of telbivudine versus entecavir in treating higher viral load chronic hepatitis B patients without cirrhosis. Journal of Viral Hepatitis. 24(S1). 29–35. 10 indexed citations
15.
Zheng, Weiping, et al.. (2017). Biological effects of bone marrow mesenchymal stem cells on hepatitis B virus in vitro. Molecular Medicine Reports. 15(5). 2551–2559. 5 indexed citations
18.
Yang, Yang, et al.. (2014). Reduction of Acute Rejection by Bone Marrow Mesenchymal Stem Cells during Rat Small Bowel Transplantation. PLoS ONE. 9(12). e114528–e114528. 17 indexed citations
19.
Zheng, Weiping, et al.. (2012). Variations in the S and P Regions of the Hepatitis B Virus Genome Under Immunosuppression In Vitro and In Vivo. Viral Immunology. 25(5). 368–378. 6 indexed citations
20.
Wang, Yu, et al.. (2006). [Study on risk factors for early postoperative infection after orthotopic liver transplantation in adults].. PubMed. 18(7). 406–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026